Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafia Bhore

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
AIDS Patient Care and Stds|January 14, 2012
Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitisMamta K Jain, Emmanuel Seremba, Rafia Bhore, et al.
Cancer|April 2, 2019
Association between depth of response and survival in patients with advanced-stage non-small cell lung cancer treated with first-line chemotherapyDaniel Morgensztern, Amy Ko, Mary O'Brien, et al.
Epilepsy Research|May 5, 2009
Cardiovascular autonomic functions in well-controlled and intractable partial epilepsiesShalini Mukherjee, Manjari Tripathi, Poodipedi S Chandra, et al.
Diabetes Care|June 23, 2012
Indexing severity of diabetic foot infection with 99mTc-WBC SPECT/CT hybrid imagingWilliam A Erdman, Ji Buethe, Rafia Bhore, et al.
The Oncologist|December 21, 2020
Analysis of the Role of Plasma 25-Hydroxyvitamin D Levels in Survival Outcomes in Patients from the Phase III MPACT Trial of Metastatic Pancreatic CancerDaniel D Von Hoff, Derek Cridebring, Olivia Yu Tian, et al.
Frontiers in Oncology|December 19, 2019
Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With <i>nab</i>-Paclitaxel and Carboplatin in Advanced Non-small Cell Lung CancerJonathan W Goldman, David M Waterhouse, Ben George, et al.
Statistics in Medicine|February 2, 2011
Evaluation metrics for biostatistical and epidemiological collaborationsDoris McGartland Rubio, Deborah J Del Junco, Rafia Bhore, et al.
AIDS Patient Care and Stds|June 28, 2012
Meta-analysis of gender differences in efficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of antiretroviral therapy (2000-2008)Guoxing Greg Soon, Min Min, Kimberly A Struble, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 25, 2016
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL studyJia-Horng Kao, Youn-Jae Lee, Jeong Heo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 19, 2016
On-treatment HCV RNA as a predictor of sustained virological response in HCV genotype 3-infected patients treated with daclatasvir and sofosbuvirKris V Kowdley, David R Nelson, Jacob P Lalezari, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
AIDS Patient Care and Stds|January 14, 2012
Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitisMamta K Jain, Emmanuel Seremba, Rafia Bhore, et al.
Cancer|April 2, 2019
Association between depth of response and survival in patients with advanced-stage non-small cell lung cancer treated with first-line chemotherapyDaniel Morgensztern, Amy Ko, Mary O'Brien, et al.
Epilepsy Research|May 5, 2009
Cardiovascular autonomic functions in well-controlled and intractable partial epilepsiesShalini Mukherjee, Manjari Tripathi, Poodipedi S Chandra, et al.
Diabetes Care|June 23, 2012
Indexing severity of diabetic foot infection with 99mTc-WBC SPECT/CT hybrid imagingWilliam A Erdman, Ji Buethe, Rafia Bhore, et al.
The Oncologist|December 21, 2020
Analysis of the Role of Plasma 25-Hydroxyvitamin D Levels in Survival Outcomes in Patients from the Phase III MPACT Trial of Metastatic Pancreatic CancerDaniel D Von Hoff, Derek Cridebring, Olivia Yu Tian, et al.
Frontiers in Oncology|December 19, 2019
Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With <i>nab</i>-Paclitaxel and Carboplatin in Advanced Non-small Cell Lung CancerJonathan W Goldman, David M Waterhouse, Ben George, et al.
Statistics in Medicine|February 2, 2011
Evaluation metrics for biostatistical and epidemiological collaborationsDoris McGartland Rubio, Deborah J Del Junco, Rafia Bhore, et al.
AIDS Patient Care and Stds|June 28, 2012
Meta-analysis of gender differences in efficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of antiretroviral therapy (2000-2008)Guoxing Greg Soon, Min Min, Kimberly A Struble, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 25, 2016
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL studyJia-Horng Kao, Youn-Jae Lee, Jeong Heo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 19, 2016
On-treatment HCV RNA as a predictor of sustained virological response in HCV genotype 3-infected patients treated with daclatasvir and sofosbuvirKris V Kowdley, David R Nelson, Jacob P Lalezari, et al.
Pageof 6